Israeli study points to potential breakthrough in spinal cord injury care – Israel & Jewish News

The Golden Hour: Redefining Survival After Spinal Cord Injury

For decades, the medical approach to spinal cord injuries (SCI) has been largely supportive. Once the initial trauma occurs, doctors focus on stabilizing the patient and managing the symptoms. However, the real battle isn’t just the initial impact—it’s the “chemical storm” that follows.

Recent breakthroughs from researchers at Tel Aviv University are shifting the paradigm. They have identified a way to interrupt the secondary cascade of damage that often makes a permanent injury far worse in the hours following the accident.

Stopping the Chemical Chain Reaction

The core of the problem is a substance called glutamate. While essential for normal brain function, an excess of it after an injury overstimulates nerve cells, triggering inflammation and cell death. Until now, there were no approved treatments to stop this specific process.

The innovative approach developed at Tel Aviv University’s Gray Faculty of Medical and Health Sciences doesn’t try to block glutamate inside the nervous system—where the blood-brain barrier often makes treatment difficult. Instead, it removes excess glutamate directly from the bloodstream.

The results in animal models have been staggering. Treated subjects showed up to 80% recovery of motor function, compared to only 30% in untreated groups. More importantly, these improvements were visible within just two days.

From the Ambulance to the ER: The Future of Emergency Care

The true potential of this therapy lies in its delivery. Because it is a simple intravenous (IV) injection that remains effective for up to eight hours, it transforms the “golden hour” of emergency medicine.

Imagine a world where first responders carry this treatment in their kits. By administering the injection at the scene of a car accident or a fall, the chemical damage can be mitigated before the patient even reaches the hospital. This could prevent irreversible nerve death and significantly reduce long-term disability.

Expanding the Horizon: Stroke and Traumatic Brain Injury (TBI)

While the current focus is on the spinal cord, the implications extend far beyond. The same glutamate-driven damage occurs during strokes and traumatic brain injuries (TBI). In stroke victims, brain damage continues even after blood flow is restored; in TBI, secondary cellular damage evolves long after the initial impact.

If human trials mirror the success of animal studies, this intravenous approach could become a standard protocol for any acute neurological event, potentially saving millions of neurons across the globe.

The Next Leap: Combining Stabilization with Regeneration

Stabilizing the injury is only half the battle. The ultimate goal is the restoration of lost function. This is where the future of regenerative medicine comes into play.

Parallel research at Tel Aviv University has already seen success in engineering human spinal cord tissues in the lab. The future trend in neurology is a “one-two punch” strategy:

• Phase 1: Neuroprotection. Use IV glutamate removal to stop the bleeding and inflammation immediately after injury.
• Phase 2: Regeneration. Implant engineered tissues or use stem cell therapy to rebuild the broken “electrical cables” of the nervous system.

By combining these two approaches, the medical community is moving closer to a reality where paralysis is no longer a permanent sentence, but a treatable condition.

Frequently Asked Questions